105 related articles for article (PubMed ID: 466976)
1. [Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].
Buzzelli G; Doni A; Lippi G; Resina A
Clin Ter; 1979 May; 89(3):251-66. PubMed ID: 466976
[No Abstract] [Full Text] [Related]
2. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
Bucalossi A; Buzzelli G; D'Alessandro A
Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
[No Abstract] [Full Text] [Related]
3. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
[No Abstract] [Full Text] [Related]
4. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
Tesi M
Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
[No Abstract] [Full Text] [Related]
5. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
[No Abstract] [Full Text] [Related]
6. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
Tesi M; Brunetti S; Caramelli L
Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
[No Abstract] [Full Text] [Related]
7. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
Kiseleva LN; Romanenko GK
Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
[No Abstract] [Full Text] [Related]
8. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
9. [Pharmacokinetics of a combination of magnesium-chlorophenoxy-isobutyrate and meso-inositol hexanicotinate].
Paltauf F; Pristautz H; el Eisch IA
Acta Med Austriaca; 1977; 4(3):120-4. PubMed ID: 930544
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].
Bolzano K; Krempler F; Haslauer F
Arzneimittelforschung; 1979; 29(10):1621-4. PubMed ID: 583231
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary study of the effects of nicotinic-N-oxide acid causing hypolipidemia administered alone or in combination with clofibrate].
Palamara G; De Luca G; Materazzi M
Boll Chim Farm; 1977 Oct; 116(10):596-600. PubMed ID: 607948
[No Abstract] [Full Text] [Related]
12. Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
Baldoni F; Egge H; Giarola P; Müller H; Cuttin S; Gibelli A; Zilliken F; de Nicola P
New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):135-8. PubMed ID: 4670445
[No Abstract] [Full Text] [Related]
13. Effect of tamoxifen on measurements of hemostasis in healthy women.
Mannucci PM; Bettega D; Chantarangkul V; Tripodi A; Sacchini V; Veronesi U
Arch Intern Med; 1996 Sep; 156(16):1806-10. PubMed ID: 8790074
[TBL] [Abstract][Full Text] [Related]
14. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol].
Sommer H
Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070
[No Abstract] [Full Text] [Related]
15. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
Turazza G; Spreafico PL; Frandoli G
Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
[No Abstract] [Full Text] [Related]
16. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
Weithmann KU; Granzer E
Artery; 1980; 8(5):475-81. PubMed ID: 7011266
[TBL] [Abstract][Full Text] [Related]
17. [The lipid-reducing efficiency of a clofibrate-inositolnicotinate combination in comparison with clofibrate. The wrong use of statistical methods--presented on an example from clinical research].
Haase W; Kluthe R; Schäfer B
Med Welt; 1975 Nov; 26(47):2157-9. PubMed ID: 1105056
[No Abstract] [Full Text] [Related]
18. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults.
Kluft C; Preston FE; Malia RG; Bertina RM; Wijngaards G; Greaves M; Verheijen JH; Dooijewaard G
Thromb Haemost; 1984 Apr; 51(2):157-64. PubMed ID: 6740547
[TBL] [Abstract][Full Text] [Related]
19. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
Priego JG; Maroto ML; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
[No Abstract] [Full Text] [Related]
20. Comparative research on the fibrinolytic action of different nicotinic acid derivatives following their prolonged administration into rabbits.
De Nicola P; Gibelli A; Turazza G
Thromb Diath Haemorrh; 1966 Jan; 15(1):231-7. PubMed ID: 5919803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
